Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
ATP + L-seryl-tRNASec
O-phospho-L-seryl-tRNASec + ADP
ATP + seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
CTP + L-seryl-tRNASec
CDP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 60% the activity of ATP
Products: -
?
dATP + L-seryl-tRNASec
dADP + O-phospho-L-seryl-tRNASec
GTP + L-seryl-tRNASec
GDP + O-phospho-L-seryl-tRNASec
ITP + L-seryl-tRNASec
IDP + O-phospho-L-seryl-tRNASec
L-threonyl-tRNASec + ATP
O-phospho-L-threonyl-tRNASec + ADP
UTP + L-seryl-tRNASec
UDP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 40% the activity of ATP
Products: -
?
additional information
?
-
ATP + L-seryl-tRNASec

ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: the enzyme does not recognize free Ser as a substrate for phosphate transfer. Ser attached to tRNASec is its obligate substrate. Neither tRNASer nor L-seryl-tRNASer is a substrate for phosphorylation
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: L-phosphoseryl-tRNA is the crucial precursor for L-selenocysteinyl-tRNA formation in archaea and eukarya. Selenocysteine formation is achieved by a two-step process: O-phosphoseryl-tRNASec kinase (PSTK) phosphorylates the endogenous Ser-tRNASec to O-phosphoseryl-tRNASec, and then this misacylated amino acid-tRNA species is converted to L-selenocysteinyl-tRNASec by Sep-tRNA:Sec-tRNA synthase (SepSecS)
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: the enzyme does not recognize free Ser as a substrate for phosphate transfer. Ser attached to tRNASec is its obligate substrate. Neither tRNASer nor L-seryl-tRNASer is a substrate for phosphorylation
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: L-phosphoseryl-tRNA is the crucial precursor for L-selenocysteinyl-tRNA formation in archaea and eukarya. Selenocysteine formation is achieved by a two-step process: O-phosphoseryl-tRNASec kinase (PSTK) phosphorylates the endogenous Ser-tRNASec to O-phosphoseryl-tRNASec, and then this misacylated amino acid-tRNA species is converted to L-selenocysteinyl-tRNASec by Sep-tRNA:Sec-tRNA synthase (SepSecS)
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: Pstk is a limiting factor for hepatic selenoprotein biosynthesis, and its mRNA expression is most strongly affected during the lipopolysaccharide (LPS)-induced acute-phase response
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: about 30% of O-phospho-L-seryltRNA[Ser]Sec is converted to L-seryl-tRNA[Ser]Sec and ATP during the course of the reaction. The kinase is specific for the two major isoforms of O-phospho-L-seryl-tRNA[Ser]Sec. Seryl-tRNA1Ser does not serve as a substrate for PSTK
Products: -
r
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: null mutants of PSTK abolish selenoprotein synthesis, demonstrating the essentiality of the enzyme for the formation of L-selenocysteinyl-tRNASec. Growth of the knockout strain is not impaired. Thus, unlike mammals, trypanosomes do not require selenoproteins for viability
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec

O-phospho-L-seryl-tRNASec + ADP
Substrates: PSTK distinguishes tRNASec from tRNASer. Unlike eukaryotic PSTK, the archaeal enzyme recognizes the acceptor stem rather than the length and secondary structure of the D-stem. The seryl moiety of L-seryl-tRNASec is not required for enzyme recognition, as PSTK efficiently phosphorylates L-threonyl-tRNASec
Products: -
?
ATP + L-seryl-tRNASec
O-phospho-L-seryl-tRNASec + ADP
Substrates: PSTK distinguishes tRNASec from tRNASer. Unlike eukaryotic PSTK, the archaeal enzyme recognizes the acceptor stem rather than the length and secondary structure of the D-stem. The seryl moiety of L-seryl-tRNASec is not required for enzyme recognition, as PSTK efficiently phosphorylates L-threonyl-tRNASec
Products: -
?
ATP + seryl-tRNASec

ADP + O-phospho-L-seryl-tRNASec
Substrates: L-phosphoseryl-tRNA is the crucial precursor for L-selenocysteinyl-tRNA formation in archaea and eukarya. Selenocysteine formation is achieved by a two-step process: O-phosphoseryl-tRNASec kinase (PSTK) phosphorylates the endogenous Ser-tRNASec to O-phosphoseryl-tRNASec, and then this misacylated amino acid-tRNA species is converted to L-selenocysteinyl-tRNASec by Sep-tRNA:Sec-tRNA synthase (SepSecS)
Products: -
?
ATP + seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: L-phosphoseryl-tRNA is the crucial precursor for L-selenocysteinyl-tRNA formation in archaea and eukarya. Selenocysteine formation is achieved by a two-step process: O-phosphoseryl-tRNASec kinase (PSTK) phosphorylates the endogenous Ser-tRNASec to O-phosphoseryl-tRNASec, and then this misacylated amino acid-tRNA species is converted to L-selenocysteinyl-tRNASec by Sep-tRNA:Sec-tRNA synthase (SepSecS)
Products: -
?
dATP + L-seryl-tRNASec

dADP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 65% the activity of ATP
Products: -
?
dATP + L-seryl-tRNASec
dADP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 65% the activity of ATP
Products: -
?
GTP + L-seryl-tRNASec

GDP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 40% the activity of ATP
Products: -
?
GTP + L-seryl-tRNASec
GDP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 40% the activity of ATP
Products: -
?
ITP + L-seryl-tRNASec

IDP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 85% the activity of ATP
Products: -
?
ITP + L-seryl-tRNASec
IDP + O-phospho-L-seryl-tRNASec
Substrates: phosphorylation at about 85% the activity of ATP
Products: -
?
L-threonyl-tRNASec + ATP

O-phospho-L-threonyl-tRNASec + ADP
Substrates: -
Products: -
?
L-threonyl-tRNASec + ATP
O-phospho-L-threonyl-tRNASec + ADP
Substrates: -
Products: -
?
additional information

?
-
Substrates: no phosphorylation activity with 5'-adenylyl (beta,gamma-methylene)diphosphonate, very low phosphorylation activity with alpha,beta-methyleneadenosine 5'-triphosphate
Products: -
?
additional information
?
-
-
Substrates: no phosphorylation activity with 5'-adenylyl (beta,gamma-methylene)diphosphonate, very low phosphorylation activity with alpha,beta-methyleneadenosine 5'-triphosphate
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
ATP + seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
ATP + L-seryl-tRNASec

ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: Pstk is a limiting factor for hepatic selenoprotein biosynthesis, and its mRNA expression is most strongly affected during the lipopolysaccharide (LPS)-induced acute-phase response
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
-
Substrates: null mutants of PSTK abolish selenoprotein synthesis, demonstrating the essentiality of the enzyme for the formation of L-selenocysteinyl-tRNASec. Growth of the knockout strain is not impaired. Thus, unlike mammals, trypanosomes do not require selenoproteins for viability
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + L-seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: -
Products: -
?
ATP + seryl-tRNASec

ADP + O-phospho-L-seryl-tRNASec
Substrates: L-phosphoseryl-tRNA is the crucial precursor for L-selenocysteinyl-tRNA formation in archaea and eukarya. Selenocysteine formation is achieved by a two-step process: O-phosphoseryl-tRNASec kinase (PSTK) phosphorylates the endogenous Ser-tRNASec to O-phosphoseryl-tRNASec, and then this misacylated amino acid-tRNA species is converted to L-selenocysteinyl-tRNASec by Sep-tRNA:Sec-tRNA synthase (SepSecS)
Products: -
?
ATP + seryl-tRNASec
ADP + O-phospho-L-seryl-tRNASec
Substrates: L-phosphoseryl-tRNA is the crucial precursor for L-selenocysteinyl-tRNA formation in archaea and eukarya. Selenocysteine formation is achieved by a two-step process: O-phosphoseryl-tRNASec kinase (PSTK) phosphorylates the endogenous Ser-tRNASec to O-phosphoseryl-tRNASec, and then this misacylated amino acid-tRNA species is converted to L-selenocysteinyl-tRNASec by Sep-tRNA:Sec-tRNA synthase (SepSecS)
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction

knockdown of TbPSTK impairs selenoprotein synthesis in the parasite procyclic form (PCF). TbPSTK and TbSEPSECS double-knockout cell lines demonstrate that Trypanosoma brucei parasite procyclic form does not depend on selenoproteins
malfunction
-
knockdown of TbPSTK impairs selenoprotein synthesis in the parasite procyclic form (PCF). TbPSTK and TbSEPSECS double-knockout cell lines demonstrate that Trypanosoma brucei parasite procyclic form does not depend on selenoproteins
-
metabolism

the enzyme is involved in the selenocysteine incorporation pathway in this primitive eukaryote
metabolism
-
the synthesis of selenocysteine, the 21st amino acid, occurs on its transfer RNA, tRNASec. tRNASec is initially aminoacylated with serine by seryl-tRNA synthetase and the resulting seryl moiety is converted to phosphoserine by O-phosphoseryl-tRNA kinase (PSTK) in eukaryotes. The selenium donor, selenophosphate is synthesized from selenide and ATP by selenophosphate synthetase. Selenocysteinyl-tRNA synthase (Sep-SecS) then uses the O-phosphoseryl-tRNASec and selenophosphate to form Sec-tRNASec in eukaryotes. Leishmania SepSecS enzyme is active and able to complement the DELTAselA deletion in Escherichia coli JS1 strain only in the presence of archaeal PSTK, indicating the conserved nature of the PSTK-SepSecS pathway, selenocysteinyl-tRNA synthase is dependent on the action of PSTK enzyme in the Sec insertion pathway
metabolism
selenocysteine biosynthesis and incorporation into selenoproteins require an intricate molecular machinery that is present, but not ubiquitous, in all domains of life. In eukaryotes it begins with tRNA[Ser]Sec acylation with L-serine by the seryl-tRNA synthetase (SerRS) followed by its conversion to Sec-tRNA[Ser]Sec, sequentially catalyzed by phosphoseryl-tRNASec kinase (PSTK) and Sec-tRNA[Ser]Sec synthase (SEPSECS). Selenophosphate synthetase (SEPHS) is a key enzyme in the Sec pathway, being responsible for catalyzing the formation of the active selenium donor for this reaction, selenophosphate, from selenide and ATP. Enzyme phosphoseryl-tRNASec kinase (PSTK) forms a stable complex with the Sec-tRNASec synthase (SEPSECS)
metabolism
-
the enzyme is involved in the selenocysteine incorporation pathway in this primitive eukaryote
-
metabolism
-
the synthesis of selenocysteine, the 21st amino acid, occurs on its transfer RNA, tRNASec. tRNASec is initially aminoacylated with serine by seryl-tRNA synthetase and the resulting seryl moiety is converted to phosphoserine by O-phosphoseryl-tRNA kinase (PSTK) in eukaryotes. The selenium donor, selenophosphate is synthesized from selenide and ATP by selenophosphate synthetase. Selenocysteinyl-tRNA synthase (Sep-SecS) then uses the O-phosphoseryl-tRNASec and selenophosphate to form Sec-tRNASec in eukaryotes. Leishmania SepSecS enzyme is active and able to complement the DELTAselA deletion in Escherichia coli JS1 strain only in the presence of archaeal PSTK, indicating the conserved nature of the PSTK-SepSecS pathway, selenocysteinyl-tRNA synthase is dependent on the action of PSTK enzyme in the Sec insertion pathway
-
metabolism
-
selenocysteine biosynthesis and incorporation into selenoproteins require an intricate molecular machinery that is present, but not ubiquitous, in all domains of life. In eukaryotes it begins with tRNA[Ser]Sec acylation with L-serine by the seryl-tRNA synthetase (SerRS) followed by its conversion to Sec-tRNA[Ser]Sec, sequentially catalyzed by phosphoseryl-tRNASec kinase (PSTK) and Sec-tRNA[Ser]Sec synthase (SEPSECS). Selenophosphate synthetase (SEPHS) is a key enzyme in the Sec pathway, being responsible for catalyzing the formation of the active selenium donor for this reaction, selenophosphate, from selenide and ATP. Enzyme phosphoseryl-tRNASec kinase (PSTK) forms a stable complex with the Sec-tRNASec synthase (SEPSECS)
-
physiological function

the enzyme is involved in the biosynthesis of selenocysteine
physiological function
-
the enzyme is essential in the selenocysteine insertion
physiological function
-
the enzyme is involved in the biosynthesis of selenocysteine
-
physiological function
-
the enzyme is essential in the selenocysteine insertion
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D146A
mutant is active in vivo
D41A
strongly reduced activity
G14W
strongly reduced activity
K142A
mutant is active in vivo
K142A/Y143A
mutant shows severely reduced activity with the Methanopyrus kandleri tRNASec substrate
K30A
mutant is defective in phosphorylation activity
N161A
mutant is defective in phosphorylation activity
R116A
mutant enzyme is 23.5fold less active than wild-type enzyme
R120A
strongly reduced activity
T19W
mutant enzyme is 2.8fold less active than wild-type enzyme
W145A
mutant is active in vivo
G14W
-
strongly reduced activity
-
K30A
-
mutant is defective in phosphorylation activity
-
N161A
-
mutant is defective in phosphorylation activity
-
R116A
-
mutant enzyme is 23.5fold less active than wild-type enzyme
-
T19W
-
mutant enzyme is 2.8fold less active than wild-type enzyme
-
K17A

strongly reduced activity
K17A
mutation abolishes catalytic activity and and inhibits tRNASec recognition
S18A

strongly reduced activity
S18A
mutation abolishes catalytic activity and and inhibits tRNASec recognition
K17A

-
strongly reduced activity
-
K17A
-
mutation abolishes catalytic activity and and inhibits tRNASec recognition
-
S18A

-
strongly reduced activity
-
S18A
-
mutation abolishes catalytic activity and and inhibits tRNASec recognition
-
additional information

truncation of the C-termional domain. Deletions of up to 98 amino acids, PSTK1-153, still show activity, albeit at a much reduced level of about 6% of the initial velocity of the intact enzyme. In vivo, PSTK1-153 is still able compensate for the Escherichia coli selA deletion. Truncation PSTK1-192 lacks the entire CTD domain and exhibits 40% residual activity. PSTK1-215 and PSTK1-240 mutants lack the terminal two and one helices of the helix bundle, respectively. PSTK1-215 mutant shows remarkably reduced activity
additional information
-
truncation of the C-termional domain. Deletions of up to 98 amino acids, PSTK1-153, still show activity, albeit at a much reduced level of about 6% of the initial velocity of the intact enzyme. In vivo, PSTK1-153 is still able compensate for the Escherichia coli selA deletion. Truncation PSTK1-192 lacks the entire CTD domain and exhibits 40% residual activity. PSTK1-215 and PSTK1-240 mutants lack the terminal two and one helices of the helix bundle, respectively. PSTK1-215 mutant shows remarkably reduced activity
additional information
-
truncation of the C-termional domain. Deletions of up to 98 amino acids, PSTK1-153, still show activity, albeit at a much reduced level of about 6% of the initial velocity of the intact enzyme. In vivo, PSTK1-153 is still able compensate for the Escherichia coli selA deletion. Truncation PSTK1-192 lacks the entire CTD domain and exhibits 40% residual activity. PSTK1-215 and PSTK1-240 mutants lack the terminal two and one helices of the helix bundle, respectively. PSTK1-215 mutant shows remarkably reduced activity
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kaiser, J.T.; Gromadski, K.; Rother, M.; Engelhardt, H.; Rodnina, M.V.; Wahl, M.C.
Structural and functional investigation of a putative archaeal selenocysteine synthase
Biochemistry
44
13315-13327
2005
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii, Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Renko, K.; Hofmann, P.J.; Stoedter, M.; Hollenbach, B.; Behrends. T.; Khrle, J.; Schweizer, U.; Schomburg, L.
Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice
FASEB J.
23
1758-1765
2009
Mus musculus (Q8BP74)
brenda
Sherrer, R.L.; O'Donoghue, P.; Sll D.
Characterization and evolutionary history of an archaeal kinase involved in selenocysteinyl-tRNA formation
Nucleic Acids Res.
36
1247-1259
2008
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii, Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Sherrer, R.L.; Ho, J.M.; Sll, D.
Divergence of selenocysteine tRNA recognition by archaeal and eukaryotic O-phosphoseryl-tRNASec kinase
Nucleic Acids Res.
36
1871-1880
2008
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii, Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Carlson, B.A.; Xu, X.M.; Kryukov, G.V.; Rao, M.; Berry, M.J.; Gladyshev, V.N.; Hatfield, D.L.
Identification and characterization of posphoseryl-tRNA[Ser]Sec kinase
Proc. Natl. Acad. Sci. USA
101
12848-12853
2004
Mus musculus (Q8BP74), Mus musculus
brenda
Yuan, J.; Palioura, S.; Salazar, J.C.; Su, D.; O'Donoghue, P.; Hohn, M.J.; Cardoso, A.M.; Whitman, W.B.; Sll, D.
RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea
Proc. Natl. Acad. Sci. USA
103
18923-18927
2006
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Aeby, E.; Palioura, S.; Pusnik, M.; Marazzi, J.; Lieberman, A.; Ullu, E.; Sll, D.; Schneider, A.
The canonical pathway for selenocysteine insertion is dispensable in Trypanosomes
Proc. Natl. Acad. Sci. USA
106
5088-5092
2009
Trypanosoma brucei
brenda
Chiba, S.; Itoh, Y.; Sekine, S.; Yokoyama, S.
Structural basis for the major role of O-phosphoseryl-tRNA kinase in the UGA-specific encoding of selenocysteine
Mol. Cell
39
410-420
2010
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Sherrer, R.L.; Araiso, Y.; Aldag, C.; Ishitani, R.; Ho, J.M.; Soell, D.; Nureki, O.
C-terminal domain of archaeal O-phosphoseryl-tRNA kinase displays large-scale motion to bind the 7-bp D-stem of archaeal tRNA(Sec)
Nucleic Acids Res.
39
1034-1041
2011
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii, Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Araiso, Y.; Sherrer, R.L.; Ishitani, R.; Ho, J.M.; Sll, D.; Nureki, O.
Structure of a tRNA-dependent kinase essential for selenocysteine decoding
Proc. Natl. Acad. Sci. USA
106
16215-16220
2009
Methanocaldococcus jannaschii (Q58933), Methanocaldococcus jannaschii, Methanocaldococcus jannaschii DSM 2661 (Q58933)
brenda
Manhas, R.; Gowri, V.S.; Madhubala, R.
Leishmania donovani encodes a functional selenocysteinyl-tRNA synthase
J. Biol. Chem.
291
1203-1220
2016
Leishmania donovani
brenda
da Silva, M.T.; Caldas, V.E.; Costa, F.C.; Silvestre, D.A.; Thiemann, O.H.
Selenocysteine biosynthesis and insertion machinery in Naegleria gruberi
Mol. Biochem. Parasitol.
188
87-90
2013
Naegleria gruberi (D2V263), Naegleria gruberi ATCC 30224 (D2V263)
brenda
da Silva, M.; E. Silva, I.; Faim, L.; Bellini, N.; Pereira, M.; Lima, A.; de Jesus, T.; Costa, F.; Watanabe, T.; Pereira, H.; Valentini, S.; Zanelli, C.; Borges, J.; Dias, M.; da Cunha, J.; Mittra, B.; Andrews, N.; Thiemann, O.
Trypanosomatid selenophosphate synthetase structure, function and interaction with selenocysteine lyase
PLoS Negl. Trop. Dis.
14
1-31
2020
Trypanosoma brucei brucei (Q38A45), Trypanosoma brucei brucei 927/4 GUTat10.1 (Q38A45)
brenda